SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,401,427 | +19.9% | 44,315 | +8.8% | 0.02% | +14.3% |
| Q2 2023 | $7,841,013 | -74.2% | 40,741 | -72.8% | 0.01% | -74.1% |
| Q1 2023 | $30,359,161 | +83.6% | 149,944 | +16.6% | 0.05% | +68.8% |
| Q4 2022 | $16,532,041 | -14.5% | 128,644 | -9.0% | 0.03% | -17.9% |
| Q3 2022 | $19,339,000 | -44.9% | 141,341 | -28.7% | 0.04% | +18.2% |
| Q2 2022 | $35,098,000 | +55.1% | 198,355 | +26.3% | 0.03% | +94.1% |
| Q1 2022 | $22,625,000 | -12.2% | 157,061 | -5.7% | 0.02% | -5.6% |
| Q4 2021 | $25,779,000 | +6.1% | 166,530 | +16.4% | 0.02% | -5.3% |
| Q3 2021 | $24,290,000 | +33.2% | 143,050 | +23.9% | 0.02% | +18.8% |
| Q2 2021 | $18,232,000 | +118.9% | 115,481 | +92.5% | 0.02% | +100.0% |
| Q1 2021 | $8,330,000 | -40.2% | 59,987 | -24.6% | 0.01% | -42.9% |
| Q4 2020 | $13,936,000 | – | 79,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |